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A cholesterol-enriched diet has been shown to adversely affect lipoprotein 
profiles and increase cardiovascular disease risk. Dietary cholesterol plays 
an important role in modulating inflammatory responses involved in ath-
erosclerosis. In the present study, the effect of Oryctes rhinoceros larva oil 
(ORO), an unsaturated fatty acid-rich animal fat, on serum lipid profile 
and some proinflammatory markers in mice fed a cholesterol-based diet 
(CBD) was investigated. Forty male Swiss albino mice were randomly 
assigned to four groups consisting of control (normal diet) and three 
experimental groups fed normal diet supplemented with ORO, CBD only 
and CBD supplemented with ORO, respectively. Serum lipid profile, 
malondialdehyde, C-reactive protein, interleukin-6 and tumour necrosis 
factor-alpha levels were evaluated before and after diet treatment.  Serum 
triacyglycerol, total cholesterol and low-density lipoprotein cholesterol 
levels were significantly reduced (P<0.05) in mice fed a CBD diet supple-
mented with ORO compared with those fed CBD without ORO. In addi-
tion, serum malondialdehyde, C-reactive protein and interleukin-6 levels 
were significantly lower in mice fed CBD suplemented with ORO com-
pared with those fed CBD only (P<0.05). These results suggest that con-
sumption of ORO improved the serum lipid profile and, in addition, may 
mitigate the attendant adverse inflammatory processes in atherosclerosis.
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Humans and animals have been reported to show consistency in the response of their serum lipid levels to fat-modified diets (1). 
A significant factor underlying the high continuing incidence of coro-
nary artery disease is a typical diet high in saturated fat and choles-
terol, both of which contribute to elevated serum cholesterol levels 
(2). A serum cholesterol level >240 mg/dL (>6.216 mmol/L) is consid-
ered to be high risk and is referred to as hypercholesterolemia (3).
Hypercholesterolemia often appears intractable and represents the 
primary cause of death in patients with the condition. Significant 
elevation in serum lipid levels, which predisposes to atherosclerosis, is 
easily monitored using early lipid profiles. 
Chronic low-grade inflammation has been shown to be associated 
with increased risk for cardiovascular and several other chronic degen-
erative diseases (4). Atherosclerosis, a chronic inflammatory disease, is 
usually characterized by cholesterol deposition, recruitment and acti-
vation of monocytes, macrophages and lymphocytes, and inflamma-
tion and fibrosis (5). Interplay among lipid and cholesterol metabolism, 
cytokines and cellular activity within arterial walls plays a crucial role 
in atherosclerosis. Interleukin (IL)-1β, IL-6, IL-8 and tumour necrosis 
factor-alpha (TNF-α) have been reported to affect lipid metabolism 
and have been implicated in the development of atherosclerotic les-
sions (6,7). Dietary fats have been shown to play an essential role in 
modulating immune and inflammatory responses, with both quantity 
and quality of fats having been shown to affect these processes (8). 
Findings from some observational studies reveal that dietary intake of 
very long-chain n-3 polyunsaturated fatty acids ≥100 mg/day in 
Western countries were associated with low concentrations of inflam-
matory cytokines including C-reactive protein (CRP), IL-6, and inter-
cellular and vascular adhesion molecules (9,10). In addition, alteration 
in cholesterol levels or metabolism by dietary fat can result in changes 
to immune and inflammatory responses (8). 
In Africa, insect consumption is a traditional and culturally accept-
able way by which low-income individuals supplement the meagre 
protein content of their high-carbohydrate diets. Interest in the use of 
insects as food has been expressed in several reports (11-13). These 
insects are usually eaten as part of a meal or a complete meal. Fat is the 
chief form of energy stored in insect larvae (14). It is usually present in 
greatest amounts in the mature insect larva before metarmorphosis 
(15). Some species of insects are eaten as a delicacy in Nigeria, while 
some are used for traditional medical practice. Among the commonly 
consumed insect species in Nigeria is Oryctes rhinoceros larva (ORL). 
A report by Ekpo and Onigbinde (13) showed that ORL contained 
38% (by dry weight) oil with a high degree of unsaturation (65%). 
Although the nutritional potential of ORL oil (ORO) has been 
reported by several authors, there is very little information regarding the 
attendant effects of its consumption in vivo on serum lipid profile. The 
aim of the present study was to evaluate the effect of dietary inclusion of 
ORO on alteration in serum cholesterol fractions and selected inflam-
matory markers in mice fed a cholesterol-based diet (CBD).
MEthOdS 
Chemicals
All chemicals and solvents used in the present study were Analar 
grade. Petroleum ether, methanol, cholesterol and thiobarbituric acid 
were obtained from Sigma Chemical Co (USA). The ELISA kit used 
for the determination of rat CRP, IL-6 and TNF-α levels was obtained 
from RayBiotech, Inc (USA).
ORL
Live ORL were collected from decaying palm trees, from which sap 
is tapped as palm wine, at Igoba village near Akure (Nigeria). The 
ORL were transported to the laboratory in an open plate within 2 h 
of collection.
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Oil extraction
Oil was extracted from the ORL using a chloroform methanol (1:2, 
v/v) mixture as described by Bligh and Dyer (16). 
Animals and diets
A total of 40 male Swiss albino mice (15 g to 22 g body weight) 
obtained from the animal laboratory of the Department of Medical 
Biochemistry, University of Ibadan, Nigeria, were used for the study. 
The animals were housed in stainless steel cages with raised wired floor 
at 30°C under standard conditions of humidity and a 12 h light/12 h 
dark cycle. They were fed standard feed (Guinea Feeds Ltd, Nigeria) 
and water ad libitum, and were housed for an initial period of two 
weeks to acclimatize to their new environment. Subsequently, after an 
overnight fast, they were weighed and randomly divided into four 
groups of 10 animals each and placed on a specified diet (control [nor-
mal diet], group 1 [ORO], group 2 [CBD] and group 3 [CBD + ORO]) 
for a period of seven weeks (Table 1). To obtain baseline levels of the 
evaluated parameters, five animals from each group were euthanized 
on day zero before commencing the feeding trial. All experimental 
protocols complied with National Institutes of Health guidelines (17). 
Blood collection and serum preparation
At the end of the feeding experiment, mice in each group were 
weighed, anesthetized (in a chloroform-saturated chamber) and eutha-
nized by jugular puncture. Blood was collected from the jugular vein 
into plain, sterile bottles for serum enzyme assays. The blood was 
allowed to stand for 30 min to clot and subsequently centrifuged at 
3000 × g for 10 min at room temperature to separate the serum (18). 
The serum samples were collected by aspiration using a Pasteur pipette 
into sterile bijou bottles and stored frozen until required for analysis, 
which was performed within 72 h.
Lipid profile assays
Triacylglycerol (TAG) levels were determined according to the 
enzymatic method using glycerol as standard (Boehringer, Germany). 
Total cholesterol (TC) was measured by the enzymatic method 
(CHOD-PAP; Boehringer, Germany) according to the procedure 
described by Allain et al (19). High-density lipoprotein (HDL) was 
separated from the serum by precipitation of lipoproteins of lower 
densities with polyethylene glycol (PEG 20,000, Fluka, Switzerland). 
After centrifugation, the cholesterol concentration in the HDL frac-
tion, which remained in the supernatant, was determined using the 
cholesterol CHOD-PAP procedure. Low-density lipoprotein (LDL) 
was precipitated using heparin at its isoelectric point (pH 5.4). 
CRP, IL-6 and tNF-α assays
CRP, IL-6 and TNF-α levels were measured using ELISA kits accord-
ing to the manufacturer’s instructions (RayBiotech, Inc, USA), with 
rat antihuman IL-6 and biotinylated rat antihuman IL-6 monoclonal 
antibodies (MAbs) or mouse antihuman TNF-α and biotinylated 
mouse antihuman TNF-α MAbs.
determination of atherogenic index
The atherogenic index (AI) for each sample was calculated using the 
formula described Slater and Sawyer (20): 
AI = TC/HDL-cholesterol
Statistical analysis
Results are presented as means ± SEM of five independent determina-
tions and analyzed for statistical significance by one-way ANOVA 
followed by Duncan multiple range test for multiple comparisons. 
Values were considered to be statistically significant at P<0.05. 
RESuLtS 
The oil extracted (21% v/v) from ORL was golden yellow in colour 
and in liquid form at room temperature. 
Results obtained for all of the evaluated parameters showed no 
significant differences (P>0.05) in baseline levels among control and 
test animals. Weekly feed intake was significantly lower in mice fed 
the modified diets compared with control (Table 2). No statistically 
significant difference (P<0.05) was observed in weekly food intake in 
mice groups fed a CBD with or without ORO supplement. Observed 
body weight changes were statistically nonsignificant between mice 
fed ORO-supplemented diets and those fed the control diet. However, 
mice fed CBD without ORO supplement showed significantly higher 
(P<0.05) body weight values compared with those fed control diet as 
well as those fed ORO-modified diets.
Lipid profile analysis showed that serum TAG, TC and LDL-
cholesterol concentrations were not significantly different (P>0.05) in 
mice fed ORO-modified diets (with or without cholesterol) and those 
fed the control diet. Mice fed CBD without ORO showed significantly 
higher (P<0.05) serum TAG, TC and LDL-cholesterol levels compared 
with those fed the control diet. Serum HDL-cholesterol was not signifi-
cantly altered (P>0.05) between mice fed modified diets and those fed 
control diet (Figure 1). The AI was significantly higher (P<0.05) in 
mice fed the ORO diet and those fed CBD without ORO compared 
with control (Figure 2). However, the AI value in mice fed CBD supple-
mented with ORO and control was not significantly different (P>0.05).
Serum malondialdehyde (MDA), CRP and IL-6 levels were signifi-
cantly increased (P<0.05) in mice fed CBD only, compared with those 
fed the control diet and those fed ORO (Figures 3 and 4). MDA, CRP 
and IL-6 concentrations were not significantly different in mice fed 
CBD supplemented with ORO compared with those fed the control 
diet. Serum CRP level was significantly higher (P<0.05) in mice fed 
the CBD with or without ORO compared with control. However, the 
Figure 1) Serum lipid profile of mice fed a cholesterol-based diet (CBD) 
supplemented with Oryctes rhinocerous larva oil (ORO). Results are 
presented as means ± SEM of five independent deteminations. The asterisks 
indicate parameter values that are significantly different from one another 
(ie, P<0.05). CHOL Cholesterol; CTR Control; HDL High-density lipo-
protein; LDL Low-density lipoprotein
Table 1
Feed composition 
Composition Control ORO CbD CbD + ORO
Maize flour 70 70 70 70
Fish meal 10 10 10 10
Groundnut cake 20 10 18 08
Cholesterol – – 2 2
Oil – 10 – 10
Total 100 100 100 100
Calories, Kcal/mol 500 500 500 500
Values presented as %. ORO Oryctes rhinocerous oil; CBD Cholesterol-
based diet
effect of O rhinoceros larva oil on serum lipid profile
Curr Res Cardiol Vol 1 No 2 Winter 2014 81
CRP level in mice fed CBD supplemented with ORO was significantly 
lower (P<0.05) compared with those fed CBD without ORO. 
dISCuSSION
The present study aimed to establish the effect of ORO on serum lipid 
levels and its attendant effects on proinflammatory markers in mice 
fed a CBD. Studies have shown that dietary fat intake positively cor-
relates with serum TC values and morbidity from coronary artery dis-
ease (21). However, several studies have demonstrated that the fatty 
acid composition of food is more strongly associated with variations in 
plasma TC concentration and development of atherosclerosis than the 
amount of fat consumed (22,23). The general picture is that saturated 
Figure 2) Effect of Oryctes rhinoceros larva oil (ORO) supplementation 
on atherogenic index in mice fed a cholesterol-based diet (CBD). Results are 
presented as mean ± SEM of five independent deteminations. CTR 
Control; LDL Low-density lipoprotein; TC Total cholesterol 
Figure 3) Effect of Oryctes rhinoceros larva oil (ORO) supplementation 
on malondialdehyde (MDA) levels in mice fed a cholesterol-based diet 
(CBD). Results are presented as mean ± SEM of five independent detemin-
ations. CTR Control
Figure 4) Effect of Oryctes rhinoceros larva oil  (ORO) supplementation 
on serum inflammatory markers in mice fed a cholesterol-based diet (CBD). 
A C-reactive protein. B Interleukin-6. C Tumour necrosis factor-alpha. 






Mean weekly feed intake and body weight changes of mice fed a cholesterol-based diet (CbD) supplemented with Oryctes 
rhinocerous oil (ORO)
Treatment group Weekly feed intake, g
body weight, g
Final Initial Change (% change)
Control 12.8±0.53* 26.4±1.14† 15.2±1.4† 11.2±0.5† (73.7)
ORO 10.1±1.11† 33.7±0.82* 21.6±1.33* 12.1±0.12† (56.0)
CBD 9.14±0.32† 33.8±1.55* 18.1±0.18†* 15.7±0.33* (86.7)
CBD + ORO 10.3±0.77† 32.3±2.13* 20.1±0.46* 12.2±0.11† (60.7)
Data presented as mean ± SEM of five independent determinations. Values with different superscripts are significantly different from one another (ie, P<0.05) 
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 fatty acids tend to increase plasma TC level and, thus, increase the risk 
for coronary artery disease, while unsaturated fatty acids have the 
opposite effect. A previous study by Ekpo and Onigbinde (24) showed 
that ORO contains more unsaturated fatty acids than saturated fatty 
acids. Supporting this fact was that the oil extracted from ORL in the 
present study and used in feed formulation was in liquid form at room 
temperature, reflecting its high level of unsaturation. This is surprising 
because most animal fats are in solid form at room temperature. 
Alteration in the concentration of major lipids such as cholesterol, 
HDL-cholesterol, LDL-cholesterol and TAG can provide useful infor-
mation regarding lipid metabolism as well as predisposition of the heart 
to atherosclerosis and its associated coronary artery diseases. TAG, LDL-
cholesterol and HDL-cholesterol are associated with lipolysis, carriers of 
plasma cholesterol and atherosclerotic tendency, respectively (25). The 
reduction in serum TC, TAG and LDL-cholesterol levels observed in 
mice fed a CBD supplemented with ORO suggests that ORO may not 
predispose animals to cardiovascular risk. This is supported by the reduc-
tion in the computed AI, a useful indicator of cardiovascular disease 
(26). These results are in agreement with the findings by Scholtz et al 
(27), in which consumption of ORO lowered serum TC and non-HDL-
cholesterol concentration compared with coconut oil.
IL-6 is the most important acute-phase protein inducer. In 
humans, IL-6 strongly stimulates hepatocytes to produce CRP, fib-
rinogen, haptoglobin and antichymotrypsin (28). IL-6 also acts syner-
gistically with other cytokines, enhancing the proliferation of 
multipotential hematopoietic progenitors and promotes the matura-
tion of human megakaryocytes (29). IL-6 has been shown to play an 
important role in atherogenesis (30). In a prospective study by Ridker 
et al (31), elevated levels of plasma IL-6 were reported to be associ-
ated with increased risk for future myocardial infarction in 404 appar-
ently healthy men during a six-year follow-up period. IL-6 may 
increase atherothrombotic risk by increasing the release of adhesion 
molecules by the endothelium, increasing the hepatic release of fib-
rinogen and having procoagulant effects on platelets (32). IL-6 has 
also been  shown to affect lipid metabolism by inhibiting lipoprotein 
lipase and stimulating lipolysis (33). In the present study, serum IL-6 
level showed a positive correlation with AI and serum TC, LDL-
cholesterol and CRP concentrations. IL-6 probably stimulates the 
production of CRP, an acute-phase response protein, which could be 
a consequence of increased oxidation of LDL-cholesterol in reponse 
to increased cholesterol deposition in the arterial walls. MDA con-
centration is a good index of lipid peroxidation. Data obtained from 
the present study show that serum MDA level positively correlated 
with serum TC and LDL-cholesterol concentrations, which are com-
ponents of the membrane with a degree of susceptibility to lipid per-
oxidation. The significant reduction in serum MDA, CRP and IL-6 
levels in mice fed a CBD supplemented with ORO confirms the 
antioxidative and anti-inflammatory potential of ORO against chol-
esterol-induced oxidative damage. 
Our study is the first to show that consumption of a diet containing 
ORO improves serum lipid profile and, in addition, represses the pro-
duction of inflammatory cytokines and acute-phase response protein (ie, 
CRP) in diet-induced hypercholesterolemic mice. This observation is of 
interest given the various effects of these proinflammatory cytokines on 
lipid metabolism and inflammatory responses of the vascular system. 
CONCLuSION
The results of the present study suggest that consumption of ORO may 
help improve serum lipid profile and, in addition, positively mitigate 
the attendant adverse inflammatory process in atherosclerosis follow-
ing a high-fat diet, thus improving cardiovascular health.
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